The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
4.92BCNY
734.72M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue (TTM)
258.33MCNY
38.56M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
-26.16%
Updated Sep 22, 2026
Beta
0.2400x
vs all stocks
Updated Sep 22, 2026
52-Week Change
-25.32%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
4.92BCNY
734.72M · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
4.93BCNY
736.52M · vs all stocks (USD)
Updated Sep 22, 2026
Price to Sales (TTM)
18.66x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 19.05×.Updated Sep 22, 2026
Price to Book (MRQ)
4.99x
Updated Sep 22, 2026
Enterprise to Revenue
19.10x
Updated Sep 22, 2026
Enterprise to EBITDA
-156.43x
Updated Sep 22, 2026
Profit Margin
-26.16%
Updated Sep 22, 2026
Operating Margin
52.75%
Updated Sep 22, 2026
Return on Assets (TTM)
-3.13%
Updated Sep 22, 2026
Return on Equity (TTM)
-7.72%
Updated Sep 22, 2026
Revenue (TTM)
258.33MCNY
38.56M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
2.09CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
-37.24%
Updated Sep 22, 2026
Gross Profit (TTM)
151.13MCNY
22.56M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
-31.54MCNY
-4.71M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
-67.59MCNY
-10.09M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
-83.62%
Updated Sep 22, 2026
Operating Cash Flow (TTM)
-5.80MCNY
-866.04K · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-19.60MCNY
-2.93M · vs all stocks (USD)
Updated Sep 22, 2026
Payout Ratio
0.00%
Updated Sep 22, 2026
Minority Interest (Equity)
2.86MCNYFY2025 · Dec 31, 2025
Revenue
555.99MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
114.05MCNYFY2025 · Dec 31, 2025
Gross Profit
441.94MCNYFY2025 · Dec 31, 2025
Operating Income
-158.07MCNY
-23.60M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-198.43MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-23.28MCNYFY2025 · Dec 31, 2025
Net Income
-175.14MCNYFY2025 · Dec 31, 2025
EBIT
-189.92MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-110.58MCNYFY2025 · Dec 31, 2025
Research & Development
114.20MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
368.32MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
6.12MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
816.78KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
8.51MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.43CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.43CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
107.55MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
107.55MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-175.14MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
21.50MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-492.18MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-513.44MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
125.32MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-175.14MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
8.90MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-127.39MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-198.55MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-21.26MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-459.60KCNYFY2025 · Dec 31, 2025
Purchase of Investments
-24.75MCNYFY2025 · Dec 31, 2025
Sale of Investments
8.55MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-37.92MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
263.60MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-303.77MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-8.08MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-4.25MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-52.49MCNYFY2025 · Dec 31, 2025
Shares Outstanding
108.06MSharesUpdated Sep 22, 2026
Float Shares
59.60MSharesUpdated Sep 22, 2026
% Held by Insiders
42.21%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
2.54%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
182.24MCNY
27.20M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
1.69CNYUpdated Sep 22, 2026
Total Debt (MRQ)
296.08MCNY
44.20M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.3064x
Updated Sep 22, 2026
Current Ratio (MRQ)
2.54x
Updated Sep 22, 2026
Book Value per Share (MRQ)
8.94CNYUpdated Sep 22, 2026
Total Assets
1.46BCNY
217.94M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
794.11MCNYFY2025 · Dec 31, 2025
Total Liabilities
467.85MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
665.94MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
103.36MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
364.49MCNYFY2025 · Dec 31, 2025
Cash
147.67MCNYFY2025 · Dec 31, 2025
Cash Equivalents
20.55MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
168.22MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
10.07MCNYFY2025 · Dec 31, 2025
Accounts Receivable
302.07MCNYFY2025 · Dec 31, 2025
Inventory
219.75MCNYFY2025 · Dec 31, 2025
Accounts Payable
125.70MCNYFY2025 · Dec 31, 2025
Short-term Debt
180.39MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.93MCNYFY2025 · Dec 31, 2025
Long-term Debt
97.59MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
77.19MCNYFY2025 · Dec 31, 2025
Retained Earnings
-56.82MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
992.19MCNY
148.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
30.40CNYUpdated Sep 22, 2026
52-Week High
78.59CNYUpdated Sep 22, 2026
52-Week Change
-25.32%
vs all stocks
Updated Sep 22, 2026
Beta
0.2400x
vs all stocks
Updated Sep 22, 2026
50-Day MA
38.18CNYUpdated Sep 22, 2026
200-Day MA
51.91CNYUpdated Sep 22, 2026
Avg 10-Day Volume
7.68MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
5.07MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
-0.2200CNYUpdated Sep 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 18.66Revenue Growth YoY: -0.37
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.59
Altman Z-Score 6.56: safe zoneNotable
Altman Z-Score: 6.56
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Companies that share the same coordination system — how they create, deliver, or capture value.